Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Wockhardt Ltd slips for fifth straight session
Wockhardt Ltd is quoting at Rs 1936.7, down 0.67% on the day as on 13:19 IST on the NSE. The stock jumped 87.69% in last one year as compared to a 6.32% slide in NIFTY and a 15.05% spurt in the Nifty Pharma index.
Nifty 50 index slides below 23,950 level; auto shares outperform as Maruti Suzuki leads charge
The key equity benchmarks continued to trade below the flat line in afternoon trade. The Nifty 50 index traded below the 23,950 level. Auto, pharma and realty index advanced while IT, banks and FMCG stocks declined.
Healthcare, banks and EVs remain long-term bets: Invesco Mutual Fund's Taher Badshah
Taher Badshah, Chief Investment Officer at Invesco Mutual Fund, expects EV adoption to increase gradually with policy support, while opportunities are emerging in power distribution alongside transmission. Badshah also said SIP inflows remain stable and mutual fund industry trends are not showing signs of concern.
Cipla Ltd soars 2.53%, up for fifth straight session
Cipla Ltd is quoting at Rs 1476.6, up 2.53% on the day as on 12:44 IST on the NSE. The stock is down 1.95% in last one year as compared to a 6.16% drop in NIFTY and a 14.71% drop in the Nifty Pharma.
Nifty Pharma index up 2%; Dr Reddy's, Ajanta, Ipca, Cipla surge up to 5%
In the past seven trading days, the Nifty Pharma index outperformed the market by soaring 5.4 per cent, as compared to 0.1 per cent decline in the Nifty 50.
Sensex falls 50 points, Nifty above 24,050; Eternal, Sun Pharma, TechM rise 1%
Indian stock markets traded mixed on Monday, with Sensex dipping slightly and Nifty inching higher amidst rising oil prices due to Iran-US tensions. While some blue-chips gained, broader markets saw a minor decline. Analysts suggest a potential market upturn due to easing FII selling and South Korea's volatility, but a deficient monsoon remains a concern. Upcoming Q1 results are expected to drive stock-specific movements.
Sensex falls 50 points, Nifty above 24,050; Eternal, Sun Pharma, TechM rise 1% - The Economic Times
Sensex falls 50 points, Nifty above 24,050; Eternal, Sun Pharma, TechM rise 1%The Economic Times
Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent Systems
Indian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving averages, with a decisive close above 24,200 crucial for further gains. Several companies like Waaree Energies, Kotak Bank, and Tata Motors are in focus due to significant developments, including US investigations, strategic partnerships, and EV expansion plans.
Nifty has more room to run; stay selective: Analysts
Indian stock markets are showing cautious optimism, with the Nifty eyeing the 24,300-25,000 zone amid ongoing volatility. Analysts recommend selective trading and specific strategies like a moderately bullish Call Spread. Top stock picks include TVS Motor, Samvardhana Motherson International, Oberoi Realty, Aurobindo Pharma, Vijaya Diagnostic Centre, and Mahindra & Mahindra Financial Services, each presenting unique buying opportunities with defined targets and stop losses.
HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 crore
HDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder Sunil Sachdeva for Rs 130 crore. This acquisition builds on a prior purchase made last month. The transaction accounts for a 0.37% stake in the company. In related news, Global Health has reported an impressive 39.7% increase in its fourth-quarter profit after tax, totaling Rs 141.7 crore.
Stocks to buy: Aurobindo Pharma, Delhivery, Ather Energy, says Ajit Mishra
Market outlook by Ajit Mishra: The analyst from Religare Broking expects Nifty to consolidate in the near-term; among stocks he recommends Delhivery, Ather Energy and Aurobindo Pharma.
Ipca Laboratories Ltd spurts 0.16%, up for fifth straight session
Ipca Laboratories Ltd is quoting at Rs 1627.6, up 0.16% on the day as on 12:44 IST on the NSE. The stock is up 19.88% in last one year as compared to a 4.96% jump in NIFTY and a 15.12% jump in the Nifty Pharma.